Literature DB >> 26263199

Introduction. Maternal immunization - Promises and concerns.

Janet A Englund1.   

Abstract

In this issue of Vaccine, the maternal immunization platform as an approach to protect mothers and infants against diverse pathogens is presented. Potential vaccine targets and the safety, science, trial designs, ethical considerations, and international perspectives focusing on low and middle income countries (LMIC) are discussed. This information provides a timely update because maternal immunization is increasingly being considered as an intervention to prevent maternal and/or neonatal disease. Prioritization of vaccine targets for maternal immunization by researchers, public health officials and health care workers needs to begin now.
Copyright © 2015 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Influenza vaccine; Maternal immunization; Pertussis vaccine; Tetanus toxoid vaccine

Mesh:

Substances:

Year:  2015        PMID: 26263199     DOI: 10.1016/j.vaccine.2015.07.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

2.  Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15-year follow-up.

Authors:  Philip R Spradling; Lisa R Bulkow; Susan E Negus; Chriss Homan; Michael G Bruce; Brian J McMahon
Journal:  Hepatology       Date:  2016-02-01       Impact factor: 17.425

3.  Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial.

Authors:  Donna M MacDougall; Beth A Halperin; Joanne M Langley; Shelly A McNeil; Donna MacKinnon-Cameron; Li Li; Scott A Halperin
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

4.  Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza.

Authors:  Mark G Thompson; De-Kun Li; Allison L Naleway; Jeannette R Ferber; Michelle L Henninger; Pat Shifflett; Leslie Z Sokolow; Roxana Odouli; Tia L Kauffman; Rebecca V Fink; Joanna Bulkley; Janet D Cragan; Sam Bozeman
Journal:  BMC Pregnancy Childbirth       Date:  2019-05-08       Impact factor: 3.007

5.  Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach.

Authors:  Dan Kajungu; Michael Muhoozi; James Stark; Daniel Weibel; Miriam C J M Sturkenboom
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

6.  Safety of Tdap vaccine in pregnant women: an observational study.

Authors:  Helen Petousis-Harris; Tony Walls; Donna Watson; Janine Paynter; Patricia Graham; Nikki Turner
Journal:  BMJ Open       Date:  2016-04-18       Impact factor: 2.692

7.  A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.

Authors:  Joanne M Langley; Naresh Aggarwal; Azhar Toma; Scott A Halperin; Shelly A McNeil; Laurence Fissette; Walthere Dewé; Maarten Leyssen; Jean-François Toussaint; Ilse Dieussaert
Journal:  J Infect Dis       Date:  2016-09-29       Impact factor: 5.226

8.  Drivers and barriers of vaccine acceptance among pregnant women in Kenya.

Authors:  Nancy A Otieno; Fredrick Otiato; Bryan Nyawanda; Maxwel Adero; Winnie N Wairimu; Dominic Ouma; Raphael Atito; Andrew Wilson; Ines Gonzalez-Casanova; Fauzia A Malik; Marc-Alain Widdowson; Saad B Omer; Sandra S Chaves; Jennifer R Verani
Journal:  Hum Vaccin Immunother       Date:  2020-03-25       Impact factor: 3.452

9.  Prevalence and risk factors associated with rural women's protected against tetanus in East Africa: Evidence from demographic and health surveys of ten East African countries.

Authors:  Alebachew Taye Belay; Setegn Much Fenta; Setegn Bayabil Agegn; Mitiku Wale Muluneh
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.